NOTCH2NLC基因GGC重复扩增与肌萎缩侧索硬化症的关联
在中国大陆545例ALS患者和1305名健康对照中,排除已知ALS致病基因突变和NOP56、AR基因重复扩增后,发现4例患者携带NOTCH2NLC基因GGC重复扩增,占比约0.73%,与健康对照相比差异有统计学意义(p=0.007)。携带扩增的ALS表型患者病情更重、进展更快,提示ALS可能是NIID的一种特定表型或NOTCH2NLC扩增是ALS的修饰因素。
要点
- NOTCH2NLC基因GGC重复扩增在ALS患者中占约0.73%,健康对照中未发现。
- 携带扩增的ALS患者病情更重、恶化更快,需警惕NIID可能。
- 对ALS患者可考虑筛查NOTCH2NLC基因GGC重复扩增。
核心结论
- ALS可能是神经元核内包涵体病(NIID)的一种特定表型,或NOTCH2NLC基因GGC扩增是ALS的修饰因素。
研究设计与样本
- 研究纳入中国大陆545例ALS患者和1305名健康对照,排除已知ALS致病基因突变及NOP56和AR基因重复扩增。
主要发现
- 4例ALS患者检出NOTCH2NLC基因GGC重复扩增,重复次数分别为44、54、96和143。
- GGC重复扩增与ALS相关(Fisher精确检验,4/545 vs 0/1305,p=0.007)。
- 与NIID肌肉无力主导型相比,携带扩增的ALS表型患者病情更重、恶化更快。
关键数值与推荐
- GGC重复扩增在ALS患者中占比约0.73%(4/545)。
- 健康对照中未发现GGC重复扩增(0/1305)。
临床怎么用
- 对ALS患者,尤其是病情进展快、表型不典型者,可考虑NOTCH2NLC基因GGC重复扩增检测。
- 检出扩增者需评估是否属于NIID谱系,并关注多系统受累。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether the GGC repeats in the NOTCH2NLC gene contribute to amyotrophic lateral sclerosis (ALS). METHODS: In this study, 545 patients with ALS and 1,305 healthy controls from mainland China were recruited. Several pathogenic mutations in known ALS-causative genes (including C9ORF72 and ATXN2) and polynucleotide repeat expansions in NOP56 and AR genes were excluded. Repeat-primed PCR and GC-rich PCR were performed to determine the GGC repeat size in NOTCH2NLC. Systematic and targeted clinical evaluations and investigations, including skin biopsy and dynamic electrophysiologic studies, were conducted in the genetically affected patients. RESULTS: GGC repeat expansion was observed in 4 patients (numbers of repeats 44, 54, 96, and 143), accounting for ≈0.73% (4 of 545) of all patients with ALS. A comparison with 1,305 healthy controls revealed that GGC repeat expansion in NOTCH2NLC was associated with ALS (Fisher exact test, 4 of 545 vs 0 of 1,305, p = 0.007). Compared to patients with the neuronal intranuclear inclusion disease (NIID) muscle weakness-dominant subtype, patients with ALS phenotype carrying the abnormal repeat expansion tended to have a severe phenotype and rapid deterioration. CONCLUSION: Our results suggest that ALS is a specific phenotype of NIID or that GGC expansion in NOTCH2NLC is a factor that modifies ALS. These findings may help clarify the pathogenic mechanism of ALS and may expand the known clinical spectrum of NIID.
引用
- Yuan Y, Liu Z, Hou X, et al. Identification of GGC repeat expansion in the NOTCH2NLC gene in amyotrophic lateral sclerosis. Neurology. 2020. PMID: 32989102. doi:10.1212/WNL.0000000000010945
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。